Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 18.54
+0.75 (4.22%)
Apr 28, 2026, 3:04 PM CST
SHE:000623 Revenue
In the year 2025, Jilin Aodong Pharmaceutical Group had annual revenue of 2.34B CNY, down -10.55%. Jilin Aodong Pharmaceutical Group had revenue of 694.88M in the quarter ending December 31, 2025, a decrease of -0.88%.
Revenue
2.34B
Revenue Growth
-10.55%
P/S Ratio
9.31
Revenue / Employee
427.61K
Employees
5,461
Market Cap
21.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.34B | -275.38M | -10.55% |
| Dec 31, 2024 | 2.61B | -838.55M | -24.31% |
| Dec 31, 2023 | 3.45B | 580.91M | 20.25% |
| Jan 1, 2023 | 2.87B | 564.45M | 24.50% |
| Jan 1, 2022 | 2.30B | 52.11M | 2.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joincare Pharmaceutical Group Industry | 14.85B |
| Apeloa Pharmaceutical Co.,Ltd | 9.50B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Tasly Pharmaceutical Group | 8.35B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.01B |
| Betta Pharmaceuticals | 3.73B |
| Tonghua Dongbao Pharmaceutical | 2.95B |
| Walvax Biotechnology | 2.42B |